Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Assi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Medical Teacher|December 3, 2011
Health of the Public: publication rate following program structure modificationAmy Chesser, Carolyn R Ahlers-Schmidt, Chigozirim Utah, et al.
Medical Teacher|October 14, 2009
Rate of publication based on required student research for a 4-week clerkshipCarolyn R Ahlers-Schmidt, Amy Chesser, Chad Ammar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2007
Graft vs. host disease after liver transplantation: a new approach is neededRoman Perri, Maha Assi, Jayant Talwalkar, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2006
Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature reviewMaha Assi, David S McKinsey, Michael R Driks, et al.
Open Forum Infectious Diseases|December 18, 2019
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive InfectionsMark Redell, Miguel Sierra-Hoffman, Maha Assi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2014
Histoplasmosis in a lung transplant recipient from a nonendemic areaElda Righi, Manuela Lugano, Maha Assi, et al.
Kansas Journal of Medicine|July 28, 2022
The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-AnalysisUmar Hayat, Muhammad Zubair Ashfaq, Luke Johnson, et al.
Drugs|October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Maha Assi, Christine Lee, et al.
Drugs|November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Maha Assi, Christine Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2012
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort studyOriol Manuel, Shahid Husain, Deepali Kumar, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Medical Teacher|December 3, 2011
Health of the Public: publication rate following program structure modificationAmy Chesser, Carolyn R Ahlers-Schmidt, Chigozirim Utah, et al.
Medical Teacher|October 14, 2009
Rate of publication based on required student research for a 4-week clerkshipCarolyn R Ahlers-Schmidt, Amy Chesser, Chad Ammar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2007
Graft vs. host disease after liver transplantation: a new approach is neededRoman Perri, Maha Assi, Jayant Talwalkar, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2006
Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature reviewMaha Assi, David S McKinsey, Michael R Driks, et al.
Open Forum Infectious Diseases|December 18, 2019
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive InfectionsMark Redell, Miguel Sierra-Hoffman, Maha Assi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2014
Histoplasmosis in a lung transplant recipient from a nonendemic areaElda Righi, Manuela Lugano, Maha Assi, et al.
Kansas Journal of Medicine|July 28, 2022
The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-AnalysisUmar Hayat, Muhammad Zubair Ashfaq, Luke Johnson, et al.
Drugs|October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Maha Assi, Christine Lee, et al.
Drugs|November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile InfectionSahil Khanna, Maha Assi, Christine Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2012
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort studyOriol Manuel, Shahid Husain, Deepali Kumar, et al.
Pageof 3